We subsequently developed a far more distinct probe, [18F]CFA, which was used in The existing analyze To guage dCK action in tumors when dealt with with a little molecule dCK inhibitor. This probe can be being analyzed inside of a medical demo at our establishment To guage variations in dCK activity pursuing cancer immunotherapy eighteen. PET probe